Cargando…
Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors
A new series of peptide-like derivatives containing different aromatic amino acids and possessing pharmacophores of COX-2 inhibitors as SO(2)Me or N(3 )attached to the para position of an end phenyl ring was synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. The synthetic r...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937080/ https://www.ncbi.nlm.nih.gov/pubmed/29755541 |
_version_ | 1783320570877706240 |
---|---|
author | Ahmaditaba, Mohammad Ali Houshdar Tehrani, Mohammad Hassan Zarghi, Afshin Shahosseini, Sorayya Daraei, Bahram |
author_facet | Ahmaditaba, Mohammad Ali Houshdar Tehrani, Mohammad Hassan Zarghi, Afshin Shahosseini, Sorayya Daraei, Bahram |
author_sort | Ahmaditaba, Mohammad Ali |
collection | PubMed |
description | A new series of peptide-like derivatives containing different aromatic amino acids and possessing pharmacophores of COX-2 inhibitors as SO(2)Me or N(3 )attached to the para position of an end phenyl ring was synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. The synthetic reactions were based on the solid phase peptide synthesis method using Wang resin. One of the analogues, i.e., compound 2d, as the representative of these series was recognized as the most effective and the highest selective COX-2 inhibitor with IC(50) value of 0.08 μM and COX-2 selectivity index of 351.2, among the other synthesized compounds. Molecular docking study was operated to determine possible binding models of compound 2d to COX-2 enzyme. The study showed that the p-azido-phenyl fragment of 2d occupied inside the secondary COX-2 binding site (Arg(513), and His(90)). The structure-activity relationships acquired disclosed that compound 2d with 4-(azido phenyl) group as pharmacophore and histidine as amino acid gives the essential geometry to provide inhibition of the COX-2 enzyme with high selectivity. Compound 2d can be a good candidate for the development of new hits of COX-2 inhibitors. |
format | Online Article Text |
id | pubmed-5937080 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-59370802018-05-11 Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors Ahmaditaba, Mohammad Ali Houshdar Tehrani, Mohammad Hassan Zarghi, Afshin Shahosseini, Sorayya Daraei, Bahram Iran J Pharm Res Original Article A new series of peptide-like derivatives containing different aromatic amino acids and possessing pharmacophores of COX-2 inhibitors as SO(2)Me or N(3 )attached to the para position of an end phenyl ring was synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. The synthetic reactions were based on the solid phase peptide synthesis method using Wang resin. One of the analogues, i.e., compound 2d, as the representative of these series was recognized as the most effective and the highest selective COX-2 inhibitor with IC(50) value of 0.08 μM and COX-2 selectivity index of 351.2, among the other synthesized compounds. Molecular docking study was operated to determine possible binding models of compound 2d to COX-2 enzyme. The study showed that the p-azido-phenyl fragment of 2d occupied inside the secondary COX-2 binding site (Arg(513), and His(90)). The structure-activity relationships acquired disclosed that compound 2d with 4-(azido phenyl) group as pharmacophore and histidine as amino acid gives the essential geometry to provide inhibition of the COX-2 enzyme with high selectivity. Compound 2d can be a good candidate for the development of new hits of COX-2 inhibitors. Shaheed Beheshti University of Medical Sciences 2018 /pmc/articles/PMC5937080/ /pubmed/29755541 Text en © 2018 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Ahmaditaba, Mohammad Ali Houshdar Tehrani, Mohammad Hassan Zarghi, Afshin Shahosseini, Sorayya Daraei, Bahram Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors |
title | Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors |
title_full | Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors |
title_fullStr | Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors |
title_full_unstemmed | Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors |
title_short | Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors |
title_sort | design, synthesis and biological evaluation of novel peptide-like analogues as selective cox-2 inhibitors |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937080/ https://www.ncbi.nlm.nih.gov/pubmed/29755541 |
work_keys_str_mv | AT ahmaditabamohammadali designsynthesisandbiologicalevaluationofnovelpeptidelikeanaloguesasselectivecox2inhibitors AT houshdartehranimohammadhassan designsynthesisandbiologicalevaluationofnovelpeptidelikeanaloguesasselectivecox2inhibitors AT zarghiafshin designsynthesisandbiologicalevaluationofnovelpeptidelikeanaloguesasselectivecox2inhibitors AT shahosseinisorayya designsynthesisandbiologicalevaluationofnovelpeptidelikeanaloguesasselectivecox2inhibitors AT daraeibahram designsynthesisandbiologicalevaluationofnovelpeptidelikeanaloguesasselectivecox2inhibitors |